Wellness Blends
KLOW Research Peptide
KLOW is a proprietary multi-peptide research blend supplied lyophilized at 80mg total peptide content per vial, composed of 50mg GHK-Cu with 10mg each of KPV, TB-500, and BPC-157. Formulated as a laboratory reference compound for multi-peptide pathway research.
$119.99 — 80mg vial
| Purity | ≥99% |
| Quantity | 80mg |
| Molecular Weight | Blend |
| Sequence | Blend: KPV + GHK-Cu + Larazotide + Orexin-A + BPC-157 (proprietary research blend) |
| Category | Wellness Blends |
| Latest batch tested | 07/08/26 |
KLOW in Research
KLOW is a proprietary multi-peptide research blend supplying 80mg total peptide content per vial, built around 50mg GHK-Cu with KPV, larazotide, orexin-A, and BPC-157. The formulation brings together compounds individually studied for anti-inflammatory signaling, epithelial repair, and tight-junction modulation into a single co-formulated research vial.
Each blend lot is third-party verified with a published certificate of analysis. Researchers who prefer single-compound control can source GHK-Cu, KPV, and BPC-157 individually from the catalog.
Research Overview
- Investigated for combined anti-inflammatory and epithelial-repair pathway activity
- Studied for tight-junction and gut-barrier modulation in preclinical models
- Research into collagen synthesis, skin remodeling, and copper-peptide signaling
- Explored for synergistic tissue-repair mechanisms across multiple peptide targets
- Preclinical profiling of blended peptide pharmacokinetics and reconstitution stability
Quality & Testing
Every KLOW batch is verified by independent third-party HPLC and mass-spectrometry testing, with a batch-specific certificate of analysis available on the COA page.
Laboratory Handling & Storage
Lyophilized peptides are supplied as a freeze-dried powder and are most stable stored cold (2–8°C), protected from light and moisture, in the original sealed vial. Under these conditions the research literature generally reports multi-year integrity for dry peptide material.
Once reconstituted in a laboratory setting, solutions are typically stored refrigerated and used within the window appropriate to the diluent and compound; repeated freeze–thaw cycles are avoided because they can promote aggregation. See our research overview on reconstitution and lyophilization for the underlying formulation science.
The GHK-Cu fraction gives reconstituted KLOW solutions a blue tint — expected, and proportional to concentration.
Frequently Asked Questions
What is in the KLOW blend?
80mg total peptide content per vial: 50mg GHK-Cu together with KPV, larazotide, orexin-A, and BPC-157 in a proprietary co-formulation.
Why use a blend rather than single compounds?
Blends suit screening-style research where combined pathway activity is the study subject; single compounds suit mechanism isolation. We supply both so the design choice stays with the researcher.
Is KLOW for human use?
No. KLOW is a research blend for in-vitro and preclinical laboratory use only — not for human consumption.